BSBE Seminar丨Dr. Qingquan CHEN from Stanford University

文摘   2024-09-05 11:02   广东  


Title: Bacteriophages in Multidrug Resistant Infections: A Tale of Two Phages 

 

09:00 am–10:00 am

6 September 2024 (Friday) 

 

Multi-function Room, 

101, W1-L1

Zoom ID: 988 8150 0325

Passcode: 241023






ABSTRACT


Pseudomonas aeruginosa (Pa), an opportunistic pathogen particularly known for causing chronic wound and pulmonary infections, poses a significant challenge in clinical settings due to its intrinsic antibiotic resistance and biofilm-forming ability. There is a critical need for alternative therapeutic strategies. Bacteriophages (phages), both lytic and lysogenic, can infect and kill bacteria. We first examine the therapeutic potential of lytic phages, investigating the impact of dose, frequency, and administration route using a mouse wound infection model. Our findings indicate that local, topical delivery is superior to intravenous injection, with higher initial local doses significantly reducing bacterial burden, and repeated, daily dosing achieving the highest rates of eradication. Building on these insights, we developed “HydroPhage,” a hyaluronan-based hydrogel system that delivers high-titer phages over one week, eradicating infections up to five times more effectively than intravenous injection. We conclude that hydrogel-based sustained phage delivery enhances the efficacy of phage therapy and offers a practical, well-tolerated option for topical application. In parallel, we delve into the role of lysogenic Pf4 phages in exacerbating Pa infections and resistance mechanisms. Using fluorescent recovery after photobleaching (FRAP), we demonstrate that Pf4 interacts with anti-Pseudomonal antibiotics via charge-based electrostatic interactions. This interaction is further intensified by the formation of organized structures with airway sputum polymers, offering new insights into the complexities of phage-bacteria-antibiotic interactions in the context of multidrug-resistant infections.



BIOGRAPHY


Dr. Qingquan Chen earned his PhD from Texas A&M University Health Science Center. Dr. Chen worked under the supervision of Dr. Carolyn L. Cannon to identify synergistic relationships of clinically used therapeutics against drug-resistant cystic fibrosis (CF) pathogens, including Pseudomonas aeruginosa (Pa). Work stemming from his Ph.D. has resulted in 7 publications and 1 patent.
After PhD, Dr. Chen began his postdoctoral training under the supervision of Dr. Paul Bollyky to understand how Pf phages contribute to antibiotic resistance in P. aeruginosa. His work has resulted in 8 publications and 1 patent.  



点击推文末尾的“阅读原文”

跳转 Zoom Meeting


来源:生命科学与生物医学工程学域





欢迎联系咨询



系统枢纽



gzsystems@hkust-gz.edu.cn



生命科学与生物医学工程博士申请咨询



bsbe@hkust-gz.edu.cn



智能交通博士申请咨询



intr@hkust-gz.edu.cn



机器人与自主系统博士申请咨询



roas@hkust-gz.edu.cn



智能制造博士申请咨询



smmg@hkust-gz.edu.cn

关注系统枢纽

及时获取新鲜资讯



社交媒体矩阵



长按二维码关注

系统枢纽微信公众号

长按二维码进入

系统枢纽微信视频号


微博搜索关注

@港科大广州系统枢纽

小红书搜索关注

@港科大广州系统枢纽


知乎搜索关注

@港科大广州系统枢纽

B站搜索关注

@港科大广州系统枢纽


今日头条搜索关注

@港科大广州系统枢纽

抖音搜索关注

@港科大广州系统枢纽

香港科技大学广州 I 系统枢纽
香港科技大学(广州)系统枢纽 官方账号Systems Hub-HKUST(GZ) Official Account
 最新文章